Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical, Instrumental, and Molecular (Circulating and Tissue microRNAs) Characterization of Patients With Cardiomyopathy to Identify Critical Patients With Severe Organ Failure to be Candidates for Cardiac Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06813443
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:52.715577+00:00
Published At
2025-02-07T00:00:00+00:00
Record Updated At
2025-02-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cardiomyopathies", "Amyloidosis Cardiac", "Fabry Disease", "Arrhythmogenic Cardiomyopathy", "Hypertrophic Cardiomyopathy (HCM)", "Laminopathies", "Dystrophia Myotonica", "Mitochondrial Cardiomyopathy", "Dilated Cardiomyopathy", "Sudden Cardiac Death", "Heart Transplantation", "Glycogen Storage Disease", "Infiltrative Cardiomyopathy", "Cardiac Magnetic Resonance Imaging", "Electrocardiogram", "Micro RNA", "Echocardiogram"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-07"
protocolSection.identificationModule.nctId
"NCT06813443"
protocolSection.identificationModule.officialTitle
"Clinical, Instrumental, and Molecular (Circulating and Tissue microRNAs) Characterization of Patients With Cardiomyopathy to Identify Critical Patients With Severe Organ Failure to be Candidates for Cardiac Transplantation"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cardiomyopathies (protocolSection.conditionsModule.conditions)
  • Amyloidosis Cardiac (protocolSection.conditionsModule.conditions)
  • Fabry Disease (protocolSection.conditionsModule.conditions)
  • Arrhythmogenic Cardiomyopathy (protocolSection.conditionsModule.conditions)
  • Hypertrophic Cardiomyopathy (HCM) (protocolSection.conditionsModule.conditions)
  • Laminopathies (protocolSection.conditionsModule.conditions)
  • Dystrophia Myotonica (protocolSection.conditionsModule.conditions)
  • Mitochondrial Cardiomyopathy (protocolSection.conditionsModule.conditions)
  • Dilated Cardiomyopathy (protocolSection.conditionsModule.conditions)
  • Sudden Cardiac Death (protocolSection.conditionsModule.conditions)
  • Heart Transplantation (protocolSection.conditionsModule.conditions)
  • Glycogen Storage Disease (protocolSection.conditionsModule.conditions)
  • Infiltrative Cardiomyopathy (protocolSection.conditionsModule.conditions)
  • Cardiac Magnetic Resonance Imaging (protocolSection.conditionsModule.conditions)
  • Electrocardiogram (protocolSection.conditionsModule.conditions)
  • Micro RNA (protocolSection.conditionsModule.conditions)
  • Echocardiogram (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.